Human adenoviruses (HAdVs) are an important cause of infections in both
immunocompetent and immunocompromised individuals, and they continue to provide …

Adoptive immunotherapy with transplant donor-derived virus-specific T cells has emerged
as a potentially curative approach for the treatment of drug-refractory EBV+ lymphomas as …

Purpose Improvement of cure rates for patients treated with allogeneic hematopoietic stem-
cell transplantation (HSCT) will require efforts to decrease treatment-related mortality from …

BACKGROUND Adoptive transfer of EBV-specific T cells can restore specific immunity in
immunocompromised patients with EBV-associated complications. METHODS We provide …

Adenoviruses result in a wide array of clinical presentations, including primarily respiratory,
gastrointestinal, genitourinary, or systemic infections. Although adenovirus causes mild …

Attenuated poxvirus modified vaccinia Ankara (MVA) is a useful viral-based vaccine for
clinical investigation, because of its excellent safety profile and property of inducing potent …

Hematopoietic stem cell transplantation (HSCT) donor–generated virus-specific T cells
(VSTs) can provide effective treatment for viral infection post-HSCT but are not readily …

Adenoviruses are non‐enveloped, double‐stranded deoxyribonucleic acid (DNA) viruses
associated with a wide range of clinical syndromes in humans (1, 2). To date, 67 …

Background Immunosuppressive therapy or T-cell depletion in transplant patients can cause
uncontrolled growth of Epstein-Barr virus (EBV)-infected B cells resulting in post-transplant …

Background aims Virus-specific T-cell immunotherapy is emerging as a promising
management strategy for virus infections in patients after hematopoietic stem cell transplant …